0001209191-23-030284.txt : 20230517 0001209191-23-030284.hdr.sgml : 20230517 20230517171535 ACCESSION NUMBER: 0001209191-23-030284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WELCH DANIEL G CENTRAL INDEX KEY: 0001206199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 23932850 MAIL ADDRESS: STREET 1: 4611 UNIVERSITY DR STREET 2: 4 UNIVERSITY PLACE CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-15 0 0001811063 Nuvation Bio Inc. NUVB 0001206199 WELCH DANIEL G C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 1 0 0 0 0 Stock Option (Right to Buy) 1.64 2023-05-15 4 A 0 366744 0.00 A 2033-05-14 Class A Common Stock 366744 366744 D 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 15, 2024); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Daniel G. Welch, by /s/ Ron A. Metzger, Attorney-in-Fact 2023-05-17